Drug intelligence / Profile preview

Xucox 90

Development stage
Unknown
Lead developer
Zaiva Lifesciences
Modality
Small Molecules
Administration
Oral
01

Overview

Xucox 90 is a generic oral formulation of etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, developed and marketed by Zaiva Lifesciences. As a non-steroidal anti-inflammatory drug (NSAID), it is primarily used to manage moderate pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. It is also indicated for the short-term treatment of moderate pain following dental surgery. By selectively inhibiting the COX-2 enzyme, it reduces the synthesis of pro-inflammatory prostaglandins while minimizing the gastrointestinal side effects typically associated with non-selective NSAIDs. The drug is commercially available in India as a 90mg tablet.

Brand names
Xucox 90Xucox90Xucox-90
Other names
etoricoxib
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Xucox 90.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xucox 90.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call